About Me
Before joining the department of Health Technology and Services research in 2020, Xavier performed his doctoral research,
"Embracing Uncertainty in Health Technology Assessment", at the Maastricht University Medical Centre+. His research interests are the use of simulation models to evaluate the value of new health care technologies and how to improve the transparency of these simulation models. Currently, Xavier is involved in research projects focusing on the early detection of (risk factors for) cardiovascular diseases. Xavier also teaches the basic principles of (early) health economic evaluations in multiple study programs (Bachelor Health Sciences and Master Biomedical Engineering).
Expertise
Medicine & Life Sciences
# Cost-Benefit Analysis
# Delivery Of Health Care
# Netherlands
# Quality-Adjusted Life Years
# Technology
# Uncertainty
Social Sciences
# Costs
# Health
Organisations
Publications
Recent
Pouwels, X. G. L. V., Sampson, C. J., & Arnold, R. J. G. (2022).
Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey.
Value in health,
25(4), 473-479.
https://doi.org/10.1016/j.jval.2021.10.001
Egmond, S. V., van Vliet, E. D., Wakkee, M., Hollestein, L. M.
, Pouwels, X. G. L. V.
, Koffijberg, H., Misirli, Y., Bakkum, R. S. L. A., Bastiaens, M. T., Kukutsch, N. A., Oosting, A. J., Plasmeijer, E. I., van Rengen, A., de Roos, K. P., Nijsten, T. E. C., de Vries, E., & de Bekker-Grob, E. W. (2022).
Efficacy, cost-minimization, and budget impact of a personalized discharge letter for basal cell carcinoma patients to reduce low-value follow-up care.
PLoS ONE,
17, [e0260978].
https://doi.org/10.1371/journal.pone.0260978
Grimm, S. E.
, Pouwels, X., Ramaekers, BLT., van, R. NT., Sankatsing, VDV., Grutters, J. P. C., & Joore, MA. (2021).
Implementation Barriers to Value of Information Analysis in Health Technology Decision Making: Results From a Process Evaluation.
Value in health,
24(8), 1126-1136.
https://doi.org/10.1016/j.jval.2021.03.013
Grimm, SE.
, Pouwels, X., Ramaekers, BLT., Wijnen, B., Otten, T., Grutters, J. P. C., & Joore, MA. (2021).
State of the ART? Two New Tools for Risk Communication in Health Technology Assessments.
PharmacoEconomics,
39(10), 1185-1196.
https://doi.org/10.1007/s40273-021-01060-3
Grimm, SE.
, Pouwels, X., Ramaekers, BLT., Wijnen, B., Knies, S., Grutters, J. P. C., & Joore, MA. (2021).
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to " TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases") (vol 16, 62, 2021): Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to “TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases”) (Orphanet Journal of Rare Diseases, (2021), 16, 1, (62), 10.1186/s13023-020-01666-4).
Orphanet Journal of Rare Diseases,
16, [320].
https://doi.org/10.1186/s13023-021-01938-7
Schneider, PP., Ramaekers, B.
, Pouwels, X., Geurts, S., Ibragimova, K., den, B. M., Vriens, B., van, D. W. Y., den, B. M., Pepels, M., Tjan-Heijnen, V., & Joore, M. (2021).
Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands.
Value in health,
24(5), 668-675.
https://doi.org/10.1016/j.jval.2020.12.007
Grimm, SE.
, Pouwels, X., Ramaekers, BLT., Wijnen, B., Knies, S., Grutters, J. P. C., & Joore, MA. (2021).
Building a trusted framework for uncertainty assessment in rare diseases: suggestions for improvement (Response to "TRUST4RD: tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases").
Orphanet Journal of Rare Diseases,
16(1), [62].
https://doi.org/10.1186/s13023-020-01666-4
Wang, J.
, Pouwels, X. G. L. V., Ramaekers, B. L. T., Frederix, G. W., van Lieshout, C., Hogenveen, R., Li, X., de Wit, G. A., Joore, M. A.
, Koffijberg, H., van Giessen, A., & Feenstra, T. (2021).
Multi-use disease models : A blueprint for application in support of health care insurance coverage policy and a case study in Diabetes Mellitus. RIVM.
https://doi.org/10.21945/RIVM-2020-0145
Witlox, W. J. A., Grimm, S. E.
, Riemsma, R., Armstrong, N., Ryder, S., Duffy, S., Carrera, V. H., Posadzki, P., Worthy, G.
, Pouwels, X. G. L. V., Ramaekers, B. L. T., Kleijnen, J., Joore, M. A., & van Asselt, A. D. I. (2021).
Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
PharmacoEconomics,
39(2), 171-180.
https://doi.org/10.1007/s40273-020-00971-x
Petersohn, S.
, Pouwels, X., Ramaekers, B., ten Cate-Hoek, A., & Joore, M. (2020).
Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study.
European journal of preventive cardiology,
27(13), 1354-1365.
https://doi.org/10.1177/2047487320913380
UT Research Information System
Google Scholar Link
Affiliated Study Programmes
Bachelor
Courses Academic Year 2022/2023
Courses in the current academic year are added at the moment they are finalised in the Osiris system. Therefore it is possible that the list is not yet complete for the whole academic year.
Courses Academic Year 2021/2022
Contact Details
Visiting Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Technohal
(building no. 18), room 3306
Hallenweg 5
7522NH Enschede
The Netherlands
Mailing Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Technohal
3306
P.O. Box 217
7500 AE Enschede
The Netherlands